Please login to the form below

Not currently logged in
Email:
Password:

New accounts: January

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October 2004 to December 2004 inclusive.

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October 2004 to December 2004 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry please email nhobson@pmlive.com

Client

Product

Therapeutic area

Winning agency

Alliance Pharmaceuticals

Alphaderm

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Aquadrate

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Acnisal

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Occlusal

Dermatology

RFA Advertising

AstraZeneca

Arimidex

Oncology

Brader Perryman

Amgen (Europe)

Aranesp

Anaemia

central branding

AstraZeneca

Nexium

Gastroenterology

RFA Advertising

Biogen

Avonex

Multiple sclerosis

Brader Perryman

Cambridge Laboratories

Gelclair

Oncology/ENT

RFA Advertising

Cambridge Laboratories

ImmuCyst

Oncology

RFA Advertising

Eden Biodesign

N/A

Corporate

Affiniti (UK)

Eli Lilly

Gemzar

Oncology

GSW-W

Novartis

Prexige

Osteoarthritis

Brader Perryman

Novartis

Exelon

Alzheimer's disease

Brader Perryman

Takeda

N/A

Corporate

Brader Perryman

Takeda

Actos

Diabetes

Brader Perryman

Takeda

Amias

Hypertension

Brader Perryman

Wyeth

Prostap

Gynaecology

Woolley Pau



2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...

Infographics